Literature DB >> 10975322

Management of acute renal failure in newborns.

J B Gouyon1, J P Guignard.   

Abstract

Acute renal failure (ARF) is a frequent clinical condition in neonatal intensive care units. Plasma creatinine concentrations should be used with some caution for ARF diagnosis in the first days of life. An intravenous fluid challenge allows differentiation of prerenal failure and intrinsic renal failure. All clinical conditions associated with hypovolemia, hypoxemia, and hypotension in the newborn infant may lead to renal insufficiency, the leading causes being perinatal anoxia-ischemia and sepsis. The initial treatment mainly relies on correction of hypotension, acidosis, and hypoxemia, in order to reduce renal vasoconstriction and improve renal perfusion. If necessary, the main renal replacement therapy is usually peritoneal dialysis even if skilled medical and nursing personnel are available in some neonatal intensive care units to perform hemofiltration and hemodiafiltration safely.

Entities:  

Mesh:

Year:  2000        PMID: 10975322     DOI: 10.1007/s004670050068

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  41 in total

1.  Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study.

Authors:  L Cataldi; R Leone; U Moretti; B De Mitri; V Fanos; L Ruggeri; G Sabatino; F Torcasio; V Zanardo; G Attardo; F Riccobene; C Martano; D Benini; L Cuzzolin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-11       Impact factor: 5.747

2.  Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions.

Authors:  Laura Cuzzolin; Vassilios Fanos; Bernadette Pinna; Maria di Marzio; Monica Perin; Paola Tramontozzi; Paola Tonetto; Luigi Cataldi
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

3.  A randomised, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome.

Authors:  D Cattarelli; M Spandrio; A Gasparoni; R Bottino; C Offer; G Chirico
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-10-04       Impact factor: 5.747

4.  The main etiologies of acute kidney injury in the newborns hospitalized in the neonatal intensive care unit.

Authors:  Hossein Emad Momtaz; Mohammad Kazem Sabzehei; Bahman Rasuli; Saadat Torabian
Journal:  J Clin Neonatol       Date:  2014-04

5.  Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.

Authors:  Istemi Han Celik; Serife Suna Oguz; Gamze Demirel; Omer Erdeve; Ugur Dilmen
Journal:  Eur J Pediatr       Date:  2011-08-02       Impact factor: 3.183

Review 6.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  Clinical Profile and Outcome of Newborns with Acute Kidney Injury in a Level 3 Neonatal Unit in Western India.

Authors:  Satvik Chaitanya Bansal; Archana Somashekhar Nimbalkar; Amit R Kungwani; Dipen Vasudev Patel; Ankur Rajinder Sethi; Somashekhar Marutirao Nimbalkar
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 8.  Management of acute kidney injury in children: a guide for pediatricians.

Authors:  Sharon P Andreoli
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

9.  Effects of low-dose dopamine on urine output in normotensive very low birth weight neonates.

Authors:  J L Crouchley; P B Smith; C M Cotten; C D Hornik; R N Goldberg; J W Foreman; J L Wynn
Journal:  J Perinatol       Date:  2013-02-28       Impact factor: 2.521

Review 10.  Acute kidney injury in children.

Authors:  Sharon Phillips Andreoli
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.